Skip to main content
Globe And Street

The world, accounted for.

Global business and finance

SectionsMenuClose

Latest news

The newest stories from Globe And Street, across every section.

Page 37 of 83

  1. SEC scrutinizes AI companies' disclosures as bubble concerns grow

    Enforcement director David Woodcock said the agency would act when companies fail to provide accurate disclosures of material information.

  2. OpenAI to curb weapons-related answers for teenage ChatGPT users

    Broader safeguards will let the chatbot stop discussions involving a fixation on violence and may lead to temporary account pauses.

  3. Tech selloff drags global stocks lower as bonds and oil rise

    Intel shares dropped 28% after results showed heavy cash consumption, while the Nasdaq lost 2.61% and investors sought U.S. government debt.

  4. Turkic leaders back closer transport links between Asia and Europe

    Kazakhstan reported 30% freight growth on the Middle Corridor, while Uzbekistan proposed a program of 100 investment and industrial projects.

  5. Nasdaq 100 faces October market value loss above $2 trillion

    Higher AI spending forecasts from major technology companies have sharpened investor concerns about returns and debt financing.

  6. EU to add €2 parcel handling fee on November 1

    The charge will apply regardless of parcel value and comes on top of a €3 duty introduced in July for shipments worth less than €150.

  7. Kuaishou's Kling AI unit completes 19.8 billion yuan funding round

    Kuaishou will retain two-thirds of the equity and 52.45% of voting rights through its Lucky Labs holding vehicle.

  8. Capgemini lifts 2026 growth forecast after revenue rises 12%

    The French IT consultancy now expects revenue growth of 9.0% to 9.5% at constant exchange rates, its second increase in guidance this year.

  9. Reddit drops 23% on user warning as Pinterest falls after revenue forecast

    Reddit cited weaker referrals from Google search, while Pinterest faced a pullback by cross-border sellers in Europe.

  10. AstraZeneca profit rises 23% as drugmaker launches savings program

    The company aims to save $1.5 billion annually, principally for reinvestment in new drugs, with restructuring charges of up to $2 billion.